Last reviewed · How we verify
Low dose gabapentin
At a glance
| Generic name | Low dose gabapentin |
|---|---|
| Also known as | Low gabapentin |
| Sponsor | Mario Negri Institute for Pharmacological Research |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Use of Driving Tests to Evaluate Patient Performance on Oral Opioids
- Feasibility of Early Gabapentin as an Intervention for Neurorecovery (PHASE4)
- Low vs. Standard Daily Doses of Antiepileptic Drugs in Newly Diagnosed, Previously Untreated Epilepsy(STANDLOW) (PHASE4)
- Efficacy of Low-Intensity Shockwave Therapy in Treating Radiation Cystitis (EARLY_PHASE1)
- Effect of PP-01 on Cannabis Withdrawal Syndrome (PHASE2)
- IV Ketamine Vs. in Esketamine for MDD TRD
- Efficacy of Gabapentin in Treating Pain in Children With SNI (Gabapentin Trial) (PHASE2)
- Opioid Free vs. Standard Perioperative Pain Regimen for Anterior Cervical Discectomy and Fusion (ACDF) Surgery (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |